Dividend
-
-
-
-
-
-
-
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing
-
-
-
-
-
-
-
Partex and Fortress Biotech (FBIO) Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform
-
-
-
-
-
-
-
Fortress Biotech (FBIO) Prices 3.94M Sharee Offering at $1.65/sh
-
-
-
-
-
-
445,874 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

